Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Chief People Officer | July 31, 2025 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date July 31, 2025 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,957 |
Ending reported balance
After 2026-07-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-07-31 · Tax withholding · Disposed 326 · Balance 23,283 F1: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on July 31, 2024. Row 2 · 2026-07-31 · Tax withholding · Disposed 326 · Balance 22,957 F1: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on July 31, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on July 31, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 5, 2026 00:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 326 | $50.21 | $16,368.46 |
DisclosureSEC source: 0001104659-26-090595 · tm2622257-1_4seq1.xml · nonDerivative · entry 2 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,957 F1 · shares: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on July 31, 2024. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 15,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019285 · tm267181-4_4seq1.xml · nonDerivative · entry 1 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,609 F1 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 615 | $59.76 | $36,752.40 |
DisclosureSEC source: 0001104659-26-017049 · tm266746-5_4seq1.xml · nonDerivative · entry 1 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,651 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| July 31, 2025 Filed Aug 5, 2026 00:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 326 | $124.54 | $40,600.04 |
DisclosureSEC source: 0001104659-26-090595 · tm2622257-1_4seq1.xml · nonDerivative · entry 1 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,283 F1 · shares: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on July 31, 2024. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:43 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014858 · tm256927-3_4seq1.xml · nonDerivative · entry 1 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,266 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,248 | $0.00 Strike: $141.05 | $0.00 |
DisclosureSEC source: 0001104659-24-085348 · tm2420711-1_4seq1.xml · derivative · entry 2 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,248 Underlying: Common Stock · 5,248 shares Expires 2034-07-31 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on July 31, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:01 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 3,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-085348 · tm2420711-1_4seq1.xml · nonDerivative · entry 1 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,190 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on July 31, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.